FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients. by Cindy Serdjebi, Johan Gagnière, Jérôme Desramé, Francine Fein, Rosine Guimbaud, Eric François, Thierry André, Jean-François Seitz, Carole Montérymard, Dominique Arsene, Julien Volet, Abakar Abakar-Mahamat, Thierry Lecomte, Véronique Guerin-Meyer, Jean-Louis Legoux, Gaël Deplanque, Pierre Guillet, Joseph Ciccolini, Côme Lepage, Laetitia Dahan

Get full text

337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept s... by Come Lepage, Harry Sokol, Julien Taieb, Thierry Lecomte, Vincent Hautefeuille, Romain Coriat, David Tougeron, Laétitia Dahan, Pierre Laurent-Puig, Jean Francois Emile, Stephano Kim, Carole Monterymard, Marine Gilabert, BEZ Jérémie, Astrid Lievre, Laurent Mineur, Jean Louis Legoux, Jean marc Phelip, Claude Capron, Claire Gallois, Violaine Randrian